Home/Filings/4/0001209191-17-046598
4//SEC Filing

Schoell Josef 4

Accession 0001209191-17-046598

CIK 0001346830other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 4:53 PM ET

Size

6.9 KB

Accession

0001209191-17-046598

Insider Transaction Report

Form 4
Period: 2017-07-26
Schoell Josef
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-07-26$2.25/sh+4,000$9,00050,000 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-07-264,0000 total
    Exercise: $2.25Exp: 2018-08-14Common Stock (4,000 underlying)
Footnotes (1)
  • [F1]Immediately exercisable.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001597186

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:53 PM ET
Size
6.9 KB